A case series evaluating the serological response of adult asthma patients to the 23-valent pneumococcal polysaccharide vaccine.

Laratta, C R; Williams, K; Vethanayagam, D; Ulanova, M; Vliagoftis, H

Laratta, C R; Williams, K; Vethanayagam, D; Ulanova, M; Vliagoftis, H.

Afiliación

Laratta CR; Pulmonary Research Group, Department of Medicine, University of Alberta, Edmonton, AB Canada.
Williams K; Medical Sciences Division, Northern Ontario School of Medicine, Lakehead University Campus, Thunder Bay, ON Canada.
Vethanayagam D; Pulmonary Research Group, Department of Medicine, University of Alberta, Edmonton, AB Canada.
Ulanova M; Medical Sciences Division, Northern Ontario School of Medicine, Lakehead University Campus, Thunder Bay, ON Canada.
Vliagoftis H; Pulmonary Research Group, Department of Medicine, University of Alberta, Edmonton, AB Canada.

Allergy Asthma Clin Immunol ; 13: 27, 2017.

Article en En | MEDLINE | ID: mdl-28596792

Palabras clave

Antibodies; Asthma; Capsular polysaccharide serotypes; Corticosteroids; Invasive pneumococcal disease; Obstructive airways disease; PPSV23; Pneumococcal polysaccharide vaccine; Pneumococcal vaccine; Prevention; Serology; Vaccination; Vaccine responsiveness

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Año: 2017 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Año: 2017 Tipo del documento: Article